Literature DB >> 22349014

Hematological cancer: a new option for patients with PTCL.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2012        PMID： 22349014     DOI： 10.1038/nrclinonc.2012.11

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Authors:  Bertrand Coiffier; Barbara Pro; H Miles Prince; Francine Foss; Lubomir Sokol; Matthew Greenwood; Dolores Caballero; Peter Borchmann; Franck Morschhauser; Martin Wilhelm; Lauren Pinter-Brown; Swaminathan Padmanabhan; Andrei Shustov; Jean Nichols; Susan Carroll; John Balser; Barbara Balser; Steven Horwitz
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.